Annals of the Rheumatic Diseases, 81(8), 1065. BMJ Publishing Group Annals of the Rheumatic Diseases, 81, 8, pp. 1065-1071 De Thurah, A, Bosch, P, Marques, A, Meissner, Y, Mukhtyar, C B, Knitza, J, Najm, A, Østerås, N, Pelle, T, Knudsen, L R, Šmucrová, H, Berenbaum, F, Jani, M, Geenen, R, Krusche, M, Pchelnikova, P, De Souza, S, Badreh, S, Wiek, D, Piantoni, S, Gwinnutt, J M, Duftner, C, Canhão, H M, Quartuccio, L, Stoilov, N, Prior, Y, Bijlsma, J W J, Zabotti, A, Stamm, T A & Dejaco, C 2022, ' 2022 EULAR points to consider for remote care in rheumatic and musculoskeletal diseases ', Annals of the Rheumatic Diseases, vol. 81, no. 8, pp. 1065-1071 . https://doi.org/10.1136/annrheumdis-2022-222341 Annals of the Rheumatic Diseases, 81, 1065-1071
Briggs, A M, Huckel Schneider, C, Slater, H, Jordan, J E, Parambath, S, Young, J J, Sharma, S, Kopansky-Giles, D, Mishrra, S, Akesson, K E, Ali, N, Belton, J, Betteridge, N, Blyth, F M, Brown, R, Debere, D, Dreinhöfer, K E, Finucane, L, Foster, H E, Gimigliano, F, Haldeman, S, Haq, S A, Horgan, B, Jain, A, Joshipura, M, Kalla, A A, Lothe, J, Matsuda, S, Mobasheri, A, Mwaniki, L, Nordin, M C, Pattison, M, Reis, F J J, Soriano, E R, Tick, H, Waddell, J, Wiek, D, Woolf, A D & March, L 2021, ' Health systems strengthening to arrest the global disability burden : Empirical development of prioritised components for a global strategy for improving musculoskeletal health ', BMJ Global Health, vol. 6, no. 6, e006045 . https://doi.org/10.1136/bmjgh-2021-006045 BMJ Global Health, Vol 6, Iss 6 (2021) BMJ Global Health
Annals of the Rheumatic Diseases, 75(6), 952-957. BMJ Publishing Group Annals of the Rheumatic Diseases, 75, 952. BMJ Publishing Group Annals of the Rheumatic Diseases, 75(6), 952-957 Strehl, C, Bijlsma, J W J, de Wit, M, Boers, M, Caeyers, N, Cutolo, M, Dasgupta, B, Dixon, W G, Geenen, R, Huizinga, T W J, Kent, A, de Thurah, A L, Listing, J, Mariette, X, Ray, D W, Scherer, H U, Seror, R, Spies, C M, Tarp, S, Wiek, D, Winthrop, K L & Buttgereit, F 2016, ' Defining conditions where long-term glucocorticoid treatment has an acceptably low level of harm to facilitate implementation of existing recommendations: viewpoints from an EULAR task force ', Annals of the Rheumatic Diseases, vol. 75, no. 6, pp. 952-957 . https://doi.org/10.1136/annrheumdis-2015-208916